APAC Gene Editing Market Size, Share, Industry Trends, Forecast Analysis To 2026

The Asia Pacific gene editing market size will surpass USD 2.1 billion by 2026. Technological advancements in gene editing have propelled APAC gene editing industry value. Research and development activities fostering genetically modified crops and animals will further the revenue stream.

Get sample copy of this research report @  https://www.graphicalresearch.com/request/1512/sample

Transgenic crops, including BT crops have set the trend with longer shelf life and supplementary nutrition. Moreover, the burgeoning Chinese population has bolstered the demand for GM vegetables and crops.

TALENs technology is forecast to remain prominent with expanding market presence among organizations vying to boost their commercial application portfolio. Prominently, TALENs have become highly sought-after in animal and plant genetic engineering. The TALENs segment held approximately 17% share of APAC gene editing market in 2019 and will expand at a considerable rate by 2026.

The CRISPR/Cas9 technology is likely to remain at the helm with its popularity soaring in modifying the genome of plants and crops to augment production. Emerging economies such as India and China are likely to count on genetically modified crops and advanced gene editing techniques. The rising footfall of the CRISPR technology is partly attributed to its cost and potent therapeutic equipment for treating diseases linked with genome mutations. APAC gene editing market share from the CRISPR/Cas9 segment is forecast to expand at a healthy CAGR of 15.5% through 2026.

The trend for gene editing will be noticeable in animal genetic engineering to enhance the health and welfare of agricultural animals. It is worth noting that it produces more nutritious meat and has remained instrumental in preventing a slew of veterinary diseases. Based on revenue, the animal genetic engineering segment surpassed USD 224 million size in 2019 and will witness a notable gain in the next few years.

Cell line engineering has gained an uptick in modifying the stem cell and stem cell research, expediting the growth of pluripotent stem cells (iPSCs) lines. Moreover, gene editing has become highly sought-after for the production of new antibodies for therapeutic applications and to engineer mammalian cells. The market share of cell line engineering segment was more than 38% in 2019 and will witness considerable growth by 2026.

Biotech and pharma companies are likely to exhibit increased demand for therapies using gene editing to diagnose and treat chronic disorders. Increasing R&D activities will gain further ground from various funds to help offset the prevalence of chronic disorders such as cancer. The regional gene editing market share from biotech and pharma companies segment will expand at a staggering CAGR of over 14.8% through 2026.

Leading companies are likely to inject funds into the India market as the trend for innovative genetic tests continues to surge in the subcontinent. Notably, surging cases of genetic disorders and growth of healthcare infrastructure have augured well for the stakeholders. India gene editing market was pegged at more than 19.5% of the total regional share in 2019 and will thrive in the next few years.

Stakeholders will potentially expand their penetration in Japan as they witness increased trend from research institutes. With the implementation of guidelines for precise modification in DNA becoming palpable, industry leaders are likely to further their presence in the region. For instance, specific guidelines were issued on the use of CRISPR/Cas9 gene technology in human embryos in japan. The genetic market value in Japan was over USD 288 million in 2019 and will grow at a sizeable rate by 2026.

Request for customization @  https://www.graphicalresearch.com/request/1512/customize-this-report

Leading companies vying to expand their portfolios are Integrated DNA Technologies, Thermo Fisher Scientific, Horizon Discovery Ltd and Origene Technologies, among others. Industry participants will potentially emphasize expanding consumer base through innovations and product launches.

Table of Contents (ToC) of the report:

Chapter 1   Methodology

1.1    Definition and forecast parameters

1.1.1    Definitions

1.1.2    Methodology and forecast parameters

1.2    Data sources

1.3    References & sources

1.3.1    Secondary

1.3.2    Primary

Chapter 2   Executive Summary

2.1    Asia Pacific gene editing market summary, 2015 - 2026

2.1.1    Country trends

2.1.2    Application trends

2.1.3    Technology trends

2.1.4    End-user trends

Browse complete Table of Contents (ToC) of this research report @ https://www.graphicalresearch.com/table-of-content/1512/asia-pacific-gene-editing-market

About Graphical Research:                              

Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.